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Previously, the E. c&i cysG gene product had been shown to sequentially methyfate uro’gen III to produce precorrin-2, hence it was given the trivial 
name uro’gen III methylase. We now report that in addition to methyiase activity, the CysG protein catalyses both the NAD’ dependent oxidation 
of precorrin-2 to sirohydrochlorin, but also the insertion of iron into this oxidized intermediate, thereby producing siroheme. Thus CysG is a 
multifunctional protein solely responsible for siroheme synthesis from uro’gen III in E. culi, and accordingly is renamed siroheme synthase. 
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1. INTRODUCTION 
Central to the biosynthesis of cysteine in bacteria, 
nature uses the 6 electron reduction of sulfite to sulfide 
to produce the latter nucleophilic form of sulfur neces- 
sary to react with 0-acetyl serine. The complex reduc- 
tase, N, 670,000, has a4 & structure and utilizes a vari- 
ety of cofactors and prosthetic groups to effect the 
transfer of electrons from NADPH to sulfite [I 1. The 
final port of exit of the electrons to sulfite is through 
siroheme, a ‘non-classical’ heme with a dimethyl-iso- 
bacteriochlorin structure [2]. 
Remarkably, sirohydr~hlo~n (the metal free form of 
siroheme) also serves as a precursor of vitamin Bj2 in 
both anaerobic and aerobic B,,-producing organisms. 
Thus in Propionibacteri~m shermanii it has been shown 
that sirohydrochlorin (factor II) re-enters the biosyn- 
thetic pathway after undergoing enzymic reduction to 
the dipyrrocorphin, precorrin-2 [3,4]. 
Precorrin-2 therefore stands at the crossroads of both 
the B,, and siroheme biosynthetic pathways (Scheme 1) 
and is synthesized from uro’gen III and S-adeno- 
sylmethionine (SAM) in Pseudomonas denitrifcans by 
uro’gen III methylase (SUMT) [5] and in E. coli by the 
rysG gene product [6,7]. Curiously, the M; of SUMT 
(Mr 26x1) is nearly half that of CysG (M, 49K), and the 
sequence of the former shows high homology to the 
C-terminal terminus (a.a. 202452) of CysG (Fig. l), 
thus suggesting that the N-terminal section of CysG 
may contain additional, previously unearthed catalytic 
activities. The formation of siroheme from precorrin-2 
involves oxidation of the latter to sirohydrochlorin (fac- 
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tor II) followed by chelation of Fe*+, Precorrin-2 is 
readily oxidized (non-ethically) in the presence of 
oxygen to factor II; however, to effect its oxidation in 
anaerobic organisms a different mechanism of oxida- 
tion is obviously at work, In this communication we 
report that NAD’ fulfills the role of cofactor in the 
oxidation catalyzed by CysG. Furthermore CysG also 
serves as a ferrochelatase, inserting Fe2+ into sirohydro- 
chlorin and, since it is a multifunctional protein capable 
of synthesizing siroheme from uro’gen III, should be 
named siroheme synthase. 
2. MATERIALS AND METHODS 
2.1. Materials 
[2,1 l-‘3C;/PBG was synthesized enzymatically from [5-‘3C]ALA 
using ALA dehydratase as previously described 181. Precorrin-2 was 
prepared using the multi-enzyme synthesis as described earlier [8], 
omitting the homocysteine degrading system. E. coliuro’gen III meth- 
yltransferase (CysG) was overexpressed from the recombinant E. coli 
strain CR256 and purified as described previously [7] with the excep 
tion of employing a linear salt gradient (O-O.4 M KCI) during DEAE 
Sephacel purification, NAD’, NADH and SAM were purchased from 
Sigma Chemical (St. Louis, MO). 
2.2. NAD’-dependent ox&we af precorrin-2 by Siroheme synthme 
The ability of CysG to function as a dehydrogena~ was assayed by 
incubating solutions of precorrin-2 (50 PM in 100 mM Tris, pH 8) 
alone or in the presence of either 0.5 mM NAD or NADP in a 
argon-purged globe box. The rate of oxidation was monitored spectro- 
photometrically by UV-VIS. For NMR samples, the incubation was 
scaled up to contain 5 mg precorrin-2, 15 mg CysG, and 0.5 mM 
NAD’ in 100 ml buffer. 
The reverse reaction, i.e. NADH dependent reduction of Factor II 
to precorrin-2, was performed in a similar manner, however using 
0.5 mM NADH and incorporating methylase M2 [8] into the reaction, 
which converts precorrin-2 (but not Factor II) to precorrin-3. The 
resultant precorrin-3 was then converted to Factor III and determined 
by TLC and NMR methods. 
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2.3. Metal insertion into si~oky~~ck~orj~ (Factor II) cufatyzed by 
Siroheme syrrtkase 
Solutions of Factor II were incubated in the presence of CysG and 
either 10 FM F&O, or 10 ,uM Cc&&. Metal con~ntrat~ons higher 
than these usually resulted in inactivation of CysG. The rate of metal 
insertion was followed by fluorescent quenching of Factor II, and tbe 
inco~oration verified by molecular weight dete~inat~on by mass 
spectrometry. 
2.4. Analytical methods 
“C-NMR spectra were obtained on a Bruker We-3OOs~ctrometer 
operating at a carbon frequency of 75.47 MHz. NMR samples were 
prepared under argon in 2 M KCU20% D@ and spectra were recorded 
at ~bient couture using bilevel low power WALTZ-16 proton 
decoupling to prevent sample beating as reported earlier [S]. Moiecu- 
Iar weights were determined by laser desorption ionization FTICR 
mass spectrometry as described previously [9]. Samples for mass spec- 
tromet~ were desalted by an lotions absorbtion onto DEAE Se- 
phadex, elution with 10% acetic acid, and lyophilization. 
3. RESULTS AND DISCUSSION 
CysG, when incubated anaerobically in the presence 
of SAM, sequentially methylates uro’gen III at C-2 and 
C-7 to form precor~n-2 (Scheme 1). Further incubation 
of CysG with precorrin-2 and SAM results in an addi- 
tional methylation at C-12 to produce the nonphysiol- 
ogical product, 2,7,12-trimethylpyrr~urphin [lo]. 
However, when NAD’ is included in the incubation a 
new, pink chromophore accumulated and was shown to 
be indistin~ishable from sirohydrochlorin (faetor II), 
the oxidized equivalent of preoorrin-2, by UV-VIS and 
‘H NMR spectroscopy. Accordingly, when a sample of 
precorrin-2 was prepared from [2,1 I-‘3C,]PBG and in- 
cubated in the presence of CysG and 0.5 mM NAD’, 
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Fig. 1. ~omolo~ between E. co& CysG and P. ~~~rr~cans uro’gen III methyltmnsfer~e (SUMT), Percent simiia~ty, 62.6; percent identity, 41.7. 
The predicted NAD(P)H binding site within the N-terminal of CysG is underlined. 
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in Fig. 2 by the complete conversion of the Cl5 meso 
carbon from sp3 (6 22, Fig. 2A) to sp2 hybridization 
(6 108, Fig. 2B). Moreover, no evidence of the forma- 
tion of the over-methylated trimethylpyrrocorphin is 
observed, even after prolonged incubation. NADP’ was 
also found to function as a cofactor for the oxidation 
though the rate of reaction was some 50 times slower 
than that with NAD’. A comparison of the amino acid 
sequence of CysG to that of other NADH dependent 
dehydrogenases [I l] reveals a potential NAD binding 
site located in the N-terminus of the protein (Fig. 1). To 
investigate this possibility ex~~men~y, a truncated 
version of the CysG protein corresponding to the C- 
terminal homolog of SUMT (Fig. 1) was prepared and 
shown to be inactive as a dehydrogenase while still re- 
taining its ability to methylate uro’gen III [12]. The 
full-length cysG gene product therefore is a multi-func- 
tional protein, with SAM dependent methylase activity 
lying entirely in the C-terminus, while the NAD’ de- 
pendent dehydrogenase activity resides, at least par- 
tially, in the N-terminal domain. 
Further experiments have also established that the 
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Fig. 2. Meso carbon regions of the “C-NMR spectra of (A) precorrin-2, derived from [2,1 I-“CJPBG, and (B) precorrin-2 incubated anaerobically 
in the presence of CysG and NAD. In this pattern of “C enrichment, C-15 is coupled to both C-14 and C-16 (downfield and not shown) giving 
rise to the observed triplets centered at 6 22 (A) and 6 108 (B) in the reduced and oxidized versions, respectively. (The remaining signals shown 
arise from C-10, C-20 and C-S.) 
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oxidation reaction catalysed by CysG is reversible, 
precorrin-2 being formed from factor II in the presence 
of NADH. While the equilibrium of the reaction lies 
heavily in the favor of formation of factor II, this equi- 
librium could be effectively shifted by including the 
C-20 methyl transferase, M-2, in the incubation. This 
enzyme catalyzes the committed step in vitamin B,, bio- 
synthesis by methylating C-20 of precorrin-2 (but not 
factor II) to form precorrin-3 [8] (Scheme 1). Thus in the 
presence of CysG, NADH and M-2, factor II is con- 
verted in good yield to precorrin-3. In E! shermun~~ it 
has been shown that factor II is reduced to precorrin 2 
allowing re-entry into the B,, pathway, presumably by 
the same enzymatic sequence [3]. 
It is known that other oxidized Bj2 intermediates, 
namely factor III [13] and factor IV [14], may be re- 
duced by an as yet uncharacterized ehydrogenase and 
become substrates for the respective Bi2 biosynthetic 
enzymes. To investigate the possibility that CysG cata- 
lyzes the former reaction, precorrin-3 was incubated 
with NAD” and CysG. Since no factor III was detected, 
the dehydrogenase activity of CysG is probably con- 
fined to the interconversion of precorrin-2 to factor II 
and yet another dehydrogenase must be responsible for 
the reduction of later B,, intermediates. 
A third catalytic activity of CysG was uncovered 
when ferrous iron was added to its incubation with 
uro’gen III, SAM and NAD’. A violet product was 
formed and identified as siroheme (Fig. 2). Subsequent 
incubations employing either precorrin-2 or factor II as 
substrates in the absence of NAD’ proved that ferrous 
iron is inserted into factor II and not into precorrin-2. 
CysG is therefore a ferrochelatase and should be named 
siroheme synthase. 
We have found that siroheme synthase is also capable 
of inserting Co’+ into factor II. It is therefore possible 
that siroheme synthase serves as the missing cobalto- 
chelatase of the anaerobic B,, producing organisms (e.g. 
Salmonella typhimurium and I! shermanii)“. Additional 
evidence that all three catalytic functions of siroheme 
synthase are required for both siroheme and B,, path- 
ways come from recent studies of cysG mutants in 
S. typhim~rium [ 151. Over 60 mutants in both the methy- 
lase domain of the siroheme synthase and the sequence 
encoding the dehydrogenase and ferrochelatase activi- 
ties all prevent both siroheme and B,, biosynthesis. Si- 
roheme synthase is therefore a multifunctional enzyme 
that, remarkably, plays a major role in two biosynthetic 
pathways. 
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